Visit COVID-19 resources

[Skip to Content]

Comment on: ‘Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ – (Eye Journal AOP)

4 March 2016

This news item is available to RCOphth members only, please log in below to access.

Members Login